Understanding and Evaluating Uncertainties in the Assessment of Benefit–Risk in Pharmaceutical Drug Development
2017 ◽
pp. 71-83
◽
2001 ◽
Vol 39
(2)
◽
pp. 395-412
◽
Keyword(s):
2007 ◽
pp. 1315-1328
◽
2003 ◽
Vol 76
(suppl_1)
◽
pp. S83-S86
◽
1988 ◽
Vol 22
(2)
◽
pp. 259-268
◽
2020 ◽
Vol 86
(10)
◽
pp. 1899-1903
◽
1998 ◽
Vol 32
(3)
◽
pp. 813-824
◽
Keyword(s):